On 5/28/24, Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a major increase of 14.9%, closing at $31.61. Moreover, trading volume in this advance was exceptionally high at 332% of normal. Relative to the market the stock has been weak over the last nine months but has risen 12.5% during the last week.
Current PriceTarget Research Rating
CORT is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Corcept Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Corcept Therapeutics has a very low Appreciation Score of 14 and a very low Power Rating of 12, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment